Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
PHASE1
The purpose of this phase I study is to test the safety of different dose l...
T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
PHASE1
The purpose of this study is to test the safety of giving the patient speci...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute:Dana- Farber/Children's Hospital